We are live on
!
Find out more
HFCIV
H&F Corporate Investors VIII Portfolio holdings
AUM
$133M
1-Year Est. Return
24.42%
This Fund
S&P 500
This Quarter
Est. Return
+0.74%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
–
AUM
$1.69B
AUM Growth
-$135M
(-7.4%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.95% |
| 2 | Technology | 30.05% |
Similar funds
NCTC
CWM
FFP
SI
DG
RHIG
VCM
DFG
H&F Corporate Investors VIII's Q2 2022 Portfolio in Review
As of Q2 2022, H&F Corporate Investors VIII held 2 positions worth $1.69B, down 7.4% from $1.83B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 55% a quarter earlier, followed by Technology.
- H&F Corporate Investors VIII's ten largest holdings make up 100% of its $1.69B portfolio in Q2 2022.
- H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q2 2022.
- H&F Corporate Investors VIII's portfolio value fell 7.4% quarter-over-quarter to $1.69B.
Based on H&F Corporate Investors VIII's 13F filing for Q2 2022, filed 9 Aug 2022.